In summary, HOPX acts as a tumour suppressor via the epigenetic regulation of SNAIL transcription, which provides a novel prognostic biomarker for NPC metastasis and therapeutic target for NPC treatment. This evidence concerns the gene SNAI1 and nasopharyngeal carcinoma.